Published on 10 May 2024 on Investing.com
The company's revenue was $93.85 million, significantly falling short of the consensus estimate of $141.16 million. Despite missing Q1 estimates, NVAX ...
Start tracking your investments with Statfolio
Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the sli...
According to FactSet, the company posted profit of $1.54 per share on $14.51 billion in sales. Sa...
The company’s performance beat Wall Street expectations, pushing its share price higher in Friday...
On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...
French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...
We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. ...
Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered int...
Boeing (BA) US planemaker Boeing is heading into a busy week, with investors watching development...
(Bloomberg) -- Sanofi entered a fresh round of exclusive negotiations to sell control of its cons...
European stocks mixed; German producer prices fall